Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2025-12-25 @ 3:06 PM
NCT ID:
NCT04707768
Pre Assignment Details:
A total of 456 participants were enrolled in the study. Participants were randomized 1:1:1 to Vadadustat 600 milligrams (mg) TIW Vadadustat 900 mg TIW or to remain on Mircera® according to the dialysis center's protocol.
Recruitment Details:
This was a randomzied, open-label, active-controlled study of the efficacy and safety of conversion from long-acting Erythropoiesis-stimulating Agent (ESA) (Methoxy polyethylene glycol-epoetin beta \[Mircera®\]) to vadadustat Three Times Weekly (TIW) for the maintenance treatment of anemia in hemodialysis participants.
Study:
NCT04707768
Study Brief:
Results Section:
NCT04707768